BKSW — Baikang Biological group Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesMicro Cap
2017 April 30th | 2018 April 30th | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 14.7 | 26.8 |
Cost of Revenue | ||
Gross Profit | 11.6 | 20.4 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Total Operating Expenses | 5.91 | 9.44 |
Operating Profit | 8.77 | 17.3 |
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | 8.68 | 17.6 |
Provision for Income Taxes | ||
Net Income After Taxes | 7.38 | 14.9 |
Minority Interest | ||
Net Income Before Extraordinary Items | ||
Net Income | 7.37 | 14.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | 7.37 | 14.9 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | 0.307 | 0.621 |
Dividends per Share |